0
Summaries for Patients |

Using a Gene Test to Better Identify Heart Disease in Patients With Chest Pain FREE

[+] Article and Author Information

The summary below is from the full report titled “Multicenter Validation of the Diagnostic Accuracy of a Blood-Based Gene Expression Test for Assessing Obstructive Coronary Artery Disease in Nondiabetic Patients.” It is in the 5 October 2010 issue of Annals of Internal Medicine (volume 153, pages 425-434). The authors are S. Rosenberg, M.R. Elashoff, P. Beineke, S.E. Daniels, J.A. Wingrove, W.G. Tingley, P.T. Sager, A.J. Sehnert, M. Yau, W.E. Kraus, L.K. Newby, R.S. Schwartz, S. Voros, S.G. Ellis, N. Tahirkheli, R. Waksman, J. McPherson, A. Lansky, M.E. Winn, N.J. Schork, and E.J. Topol for the PREDICT (Personalized Risk Evaluation and Diagnosis in the Coronary Tree) Investigators.


Ann Intern Med. 2010;153(7):I-20. doi:10.7326/0003-4819-153-7-201010050-00001
Text Size: A A A

What is the problem and what is known about it so far?

When patients have chest pain, their physicians can have difficulty deciding whether it is a sign of disease in the blood vessels around the heart, called coronary artery disease (CAD). To evaluate the risk for CAD, physicians can use information gained from studies of large groups of patients, knowing that older persons, men, smokers, and diabetic persons have a higher risk for CAD. Physicians can also obtain heart tracings (electrocardiograms) or stress tests that can indicate signs of damage or a problem with the heart's blood supply. However, many patients still go through a costly and somewhat risky test called coronary angiography (in which a catheter is placed through a blood vessel in the arm or groin to examine blood vessels around the heart with dye) but are found not to have CAD, whereas others are found to have CAD despite few signs or risk factors. Therefore, better approaches are needed to identify patients with chest pain who are more likely to have CAD. Analysis of a patient's genes may be a useful tool to help distinguish patients with CAD.

Why did the researchers do this particular study?

To investigate how well their previously developed gene test, with a score based on the pattern of 23 genes that may be associated with having CAD, performed in patients who had chest pain.

Who was studied?

526 nondiabetic patients with chest pain or another indication for coronary angiography.

How was the study done?

The patients had their gene test score determined from a blood sample and then underwent coronary angiography to evaluate whether they had significant disease, defined as narrowing of at least 1 heart blood vessel by 50% or more. The authors then compared the effectiveness of the gene test score in identifying patients who did or did not have CAD with that of 3 other CAD risk measures.

What did the researchers find?

The gene test modestly improved physicians' ability to find patients with CAD compared with a measure that looks at the type of chest pain and some patient characteristics. Compared with using more clinical information available to the physician, the improvement from using the gene test was small. The test was better able to identify patients who had the disorder than those who did not.

What were the limitations of the study?

The study patients were referred for evaluation of chest pain, so they had an increased risk for heart disease. The gene test could not be performed on patients with certain types of diseases, such as diabetes or rheumatoid arthritis, and is expensive.

What are the implications of the study?

These results suggest that further work is needed to examine how a gene test score can complement other ways of distinguishing patients who have clinically important CAD from those who do not.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Journal Club
Related Point of Care
Topic Collections

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)